States Face Fiscal Strain as Welfare Spending Weighs on Revenue Growth Morgan Stanley Heatwave Intensifies Across Parts of India Straining Healthcare Systems Endurance Technologies IPO Opens Key Details and Market Implications Birds Nest on Ford F250 Delays Vehicle Sale Legal Implications for Dealerships Meta Platforms Plans 6065 Billion AI and Data Center Investment Accelerating Tech Spending Race General Motors Introduces AllElectric Cadillac Vistiq with 300Mile Range QH Q4 2021 Earnings Massive EPS Miss Highlights Operational Challenges CIMN Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Market Reaction Volato Group Inc SOAR Q2 2025 Earnings Positive EPS Reported Amid Market Caution Ashland Q1 2026 Earnings EPS Misses Estimates as Stock Gains Ground American Shared Hospital Services Q1 2026 Earnings Significant EPS Miss as Losses Deepen GRI Q1 2026 Earnings WiderThanExpected Loss Deepens as PreRevenue Biotech Faces Headwinds Tennessee Valley Authority TVE Holds Steady Near Support as Utilities Sector Shows Resilience Alliancebernstein Global High Income Fund AWF Holds Steady Near Resistance as YieldSeeking Investors Remain Cautious Inflection Point Acquisition Corp V IPEX Holds Steady Near Trust Value at 1048 AXIA Energia AXIA Retreats from Resistance Support Levels Under Scrutiny Victorias Secret Co VSCO Shares Surge Nearly 4 as Momentum Builds Above Key Support BP Ousts Chairman Amid Allegations of Bullying Conduct FKWL Q1 2026 Earnings Significant EPS Miss Sends Shares Lower Activate Energy AEAQW Warrants Edge Higher as Stock Tests Key Resistance Digi International Inc DGII Surges Over 3 as Positive Momentum Builds Afya Limited AFYA Edges Higher as Shares Hold Steady Near Support KF Growth Acquisition Corp II Rights KFIIR Hovers at 010 as Trading Remains Flat Diana Shipping DSX Slides 4 as Dry Bulk Weakness Weighs on Sentiment Goldman Sachs BDC GSBD Hovers Near Support as Dividend Appeal Offsets Tepid Volume 908 Devices MASS Climbs 3 as Shares Test Key Resistance at 857 Axsome Therapeutics Holds Near Resistance as Biotech Sector Shows Mixed Signals